Krista Patterson and Jonathan Wigser have made a planned gift commitment of their estate to Duke Children's, Duke Cancer Institute, School of Medicine, and Fuqua School of Business.

In honor of DCI's 50th anniversary, our amazing donors helped us raise more than $86 million for cancer research and care.

When Felicia Pagliuca arrived at Duke as a first-year undergraduate student from Asheville, she was only 16, but she was already fascinated by biology and physics.

A friend of Duke Health understands firsthand the struggle of being overweight. “Being overweight comes with a myriad of medical, physical, and emotional problems,” said the anonymous donor, of Rye Brook, New York. “For me, it was about my own self-esteem and wanting to improve my health.” 

Duke Health, in partnership with the Durham County Department of Public Health, has been awarded a grant totaling $750,000 from The Duke Endowment.

A Duke Children's clinic finds the perfect match in a supporter with a passion for helping those who need it most.

The choice to become a Duke Children's donor launched George Grody down a path of giving that recently topped $1 million.

Diego Bohórquez, PhD, associate professor in medicine, has become known as a “gut-brain neuroscientist.” His team has shown that neuropod cells, a type of sensor cell in the gut, communicate with the brain and help influence decision making about food. This work opens up the possibility of targeting the gut to treat mental health disorders and has been recognized by the U.S. National Academy of Sciences, the office of the Director of the National Institutes of Health (NIH), the New Yorker, and more.

In 2021, a baby boy named Easton Sinnamon was the first person in the world to receive a combination heart transplant and allogeneic processed thymus tissue implantation. Six months later, a video showed Easton smiling and playing in a high chair, and tests indicated that the processed thymus tissue was working: building the T cells needed for a well-functioning immune system.

To improve the survival of patients with brain tumors, Vidya Chandramohan, PhD, focuses on developing bacterial toxin-based therapies for glioblastoma.